Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 392

1.

Mediterranean Diet and NAFLD: What We Know and Questions That Still Need to Be Answered.

Plaz Torres MC, Aghemo A, Lleo A, Bodini G, Furnari M, Marabotto E, Miele L, Giannini EG.

Nutrients. 2019 Dec 5;11(12). pii: E2971. doi: 10.3390/nu11122971. Review.

2.

Multimodal sequential treatment for occluded TIPS: case report and review of literature.

De Matthaeis N, Di Stasi C, Pizzolante F, Manfredi R, Rapaccini GL, Miele L.

Clin Mol Hepatol. 2019 Nov 18. doi: 10.3350/cmh.2019.0056. [Epub ahead of print] No abstract available.

3.

Liver alterations in anorexia nervosa are not caused by insulin resistance.

Fanin A, Miele L, Bertolini E, Giorgini A, Pontiroli AE, Benetti A.

Intern Emerg Med. 2019 Nov 16. doi: 10.1007/s11739-019-02227-9. [Epub ahead of print]

PMID:
31734856
4.

A Role for the Biological Clock in Liver Cancer.

Mazzoccoli G, Miele L, Marrone G, Mazza T, Vinciguerra M, Grieco A.

Cancers (Basel). 2019 Nov 11;11(11). pii: E1778. doi: 10.3390/cancers11111778. Review.

5.

Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia.

Basile U, Marino M, Gragnani L, Napodano C, Gulli F, Pocino K, Lorini S, Santini SA, Basile V, Miele L, Zignego AL, Rapaccini GL.

J Immunol Methods. 2019 Oct 25:112687. doi: 10.1016/j.jim.2019.112687. [Epub ahead of print]

PMID:
31669506
6.

β-Klotho gene variation is associated with liver damage in children with NAFLD.

Dongiovanni P, Crudele A, Panera N, Romito I, Meroni M, De Stefanis C, Palma A, Comparcola D, Fracanzani AL, Miele L, Valenti L, Nobili V, Alisi A.

J Hepatol. 2019 Oct 23. pii: S0168-8278(19)30613-0. doi: 10.1016/j.jhep.2019.10.011. [Epub ahead of print]

7.

Platelets and Hepatocellular Cancer: Bridging the Bench to the Clinics.

Lai Q, Vitale A, Manzia TM, Foschi FG, Levi Sandri GB, Gambato M, Melandro F, Russo FP, Miele L, Viganò L, Burra P, Giannini EG; Associazione Italiana per lo Studio del Fegato (AISF) HCC Special Interest Group.

Cancers (Basel). 2019 Oct 15;11(10). pii: E1568. doi: 10.3390/cancers11101568. Review.

8.

Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation.

Nicoletti A, Ponziani FR, Biolato M, Valenza V, Marrone G, Sganga G, Gasbarrini A, Miele L, Grieco A.

World J Gastroenterol. 2019 Sep 7;25(33):4814-4834. doi: 10.3748/wjg.v25.i33.4814. Review.

9.

Health and Racial Disparity in Breast Cancer.

Yedjou CG, Sims JN, Miele L, Noubissi F, Lowe L, Fonseca DD, Alo RA, Payton M, Tchounwou PB.

Adv Exp Med Biol. 2019;1152:31-49. doi: 10.1007/978-3-030-20301-6_3. Review.

PMID:
31456178
10.

NAFLD in children: new genes, new diagnostic modalities and new drugs.

Nobili V, Alisi A, Valenti L, Miele L, Feldstein AE, Alkhouri N.

Nat Rev Gastroenterol Hepatol. 2019 Sep;16(9):517-530. doi: 10.1038/s41575-019-0169-z. Epub 2019 Jul 5. Review.

PMID:
31278377
11.

Individual and combined presenilin 1 and 2 knockouts reveal that both have highly overlapping functions in HEK293T cells.

Lessard CB, Rodriguez E, Ladd TB, Minter LM, Osborne BA, Miele L, Golde TE, Ran Y.

J Biol Chem. 2019 Jul 19;294(29):11276-11285. doi: 10.1074/jbc.RA119.008041. Epub 2019 Jun 5.

PMID:
31167792
12.

Corrigendum: Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells.

Sorrentino C, Hossain F, Rodriguez PC, Sierra RA, Pannuti A, Hatfield S, Osborne BA, Minter LM, Miele L, Morello S.

Front Immunol. 2019 May 3;10:935. doi: 10.3389/fimmu.2019.00935. eCollection 2019.

13.

Leptin produced by obesity-altered adipose stem cells promotes metastasis but not tumorigenesis of triple-negative breast cancer in orthotopic xenograft and patient-derived xenograft models.

Sabol RA, Bowles AC, Côté A, Wise R, O'Donnell B, Matossian MD, Hossain FM, Burks HE, Del Valle L, Miele L, Collins-Burow BM, Burow ME, Bunnell BA.

Breast Cancer Res. 2019 May 22;21(1):67. doi: 10.1186/s13058-019-1153-9.

14.

A Qualitative Study Exploring Barriers and Facilitators of Enrolling Underrepresented Populations in Clinical Trials and Biobanking.

Davis TC, Arnold CL, Mills G, Miele L.

Front Cell Dev Biol. 2019 Apr 30;7:74. doi: 10.3389/fcell.2019.00074. eCollection 2019.

15.

Drug resistance profiling of a new triple negative breast cancer patient-derived xenograft model.

Matossian MD, Burks HE, Elliott S, Hoang VT, Bowles AC, Sabol RA, Wahba B, Anbalagan M, Rowan B, Abazeed ME, Bunnell BA, Moroz K, Miele L, Rhodes LV, Jones SD, Martin EC, Collins-Burow BM, Burow ME.

BMC Cancer. 2019 Mar 7;19(1):205. doi: 10.1186/s12885-019-5401-2.

16.

Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease.

Pelusi S, Baselli G, Pietrelli A, Dongiovanni P, Donati B, McCain MV, Meroni M, Fracanzani AL, Romagnoli R, Petta S, Grieco A, Miele L, Soardo G, Bugianesi E, Fargion S, Aghemo A, D'Ambrosio R, Xing C, Romeo S, De Francesco R, Reeves HL, Valenti LVC.

Sci Rep. 2019 Mar 6;9(1):3682. doi: 10.1038/s41598-019-39998-2.

17.

Neighborhood Social Determinants of Triple Negative Breast Cancer.

Hossain F, Danos D, Prakash O, Gilliland A, Ferguson TF, Simonsen N, Leonardi C, Yu Q, Wu XC, Miele L, Scribner R.

Front Public Health. 2019 Feb 18;7:18. doi: 10.3389/fpubh.2019.00018. eCollection 2019.

18.

Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells.

Sorrentino C, Hossain F, Rodriguez PC, Sierra RA, Pannuti A, Osborne BA, Minter LM, Miele L, Morello S.

Front Immunol. 2019 Feb 7;10:162. doi: 10.3389/fimmu.2019.00162. eCollection 2019. Erratum in: Front Immunol. 2019 May 03;10:935.

19.

Prostate Cancer Disparity, Chemoprevention, and Treatment by Specific Medicinal Plants.

Yedjou CG, Mbemi AT, Noubissi F, Tchounwou SS, Tsabang N, Payton M, Miele L, Tchounwou PB.

Nutrients. 2019 Feb 4;11(2). pii: E336. doi: 10.3390/nu11020336. Review.

20.

Acute HEV hepatitis: clinical and laboratory diagnosis.

Marrone G, Biolato M, Mercurio G, Capobianchi MR, Garbuglia AR, Liguori A, Vassallo G, Gasbarrini A, Miele L, Grieco A.

Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):764-770. doi: 10.26355/eurrev_201901_16891.

21.

Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease.

Biolato M, Manca F, Marrone G, Cefalo C, Racco S, Miggiano GA, Valenza V, Gasbarrini A, Miele L, Grieco A.

World J Gastroenterol. 2019 Jan 28;25(4):509-520. doi: 10.3748/wjg.v25.i4.509.

22.

Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways.

Hossain F, Sorrentino C, Ucar DA, Peng Y, Matossian M, Wyczechowska D, Crabtree J, Zabaleta J, Morello S, Del Valle L, Burow M, Collins-Burow B, Pannuti A, Minter LM, Golde TE, Osborne BA, Miele L.

Front Oncol. 2018 Dec 4;8:575. doi: 10.3389/fonc.2018.00575. eCollection 2018.

23.

Moving Breast Cancer Therapy up a Notch.

Mollen EWJ, Ient J, Tjan-Heijnen VCG, Boersma LJ, Miele L, Smidt ML, Vooijs MAGG.

Front Oncol. 2018 Nov 20;8:518. doi: 10.3389/fonc.2018.00518. eCollection 2018. Review.

24.

A polymorphism in the Irisin-encoding gene (FNDC5) associates with hepatic steatosis by differential miRNA binding to the 3'UTR.

Metwally M, Bayoumi A, Romero-Gomez M, Thabet K, John M, Adams LA, Huo X, Aller R, García-Monzón C, Teresa Arias-Loste M, Bugianesi E, Miele L, Gallego-Durán R, Fischer J, Berg T, Liddle C, Qiao L, George J, Eslam M.

J Hepatol. 2019 Mar;70(3):494-500. doi: 10.1016/j.jhep.2018.10.021. Epub 2018 Oct 31.

PMID:
30389552
25.

Whole Genome Transcriptome Analysis of the Association between Obesity and Triple-Negative Breast Cancer in Caucasian Women.

Mamidi TKK, Wu J, Tchounwou PB, Miele L, Hicks C.

Int J Environ Res Public Health. 2018 Oct 23;15(11). pii: E2338. doi: 10.3390/ijerph15112338.

26.

IgG cryoglobulinemia.

Gulli F, Basile U, Gragnani L, Napodano C, Pocino K, Miele L, Santini SA, Zignego AL, Gasbarrini A, Rapaccini GL.

Eur Rev Med Pharmacol Sci. 2018 Sep;22(18):6057-6062. doi: 10.26355/eurrev_201809_15943.

27.

PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease.

Tortora R, Rispo A, Alisi A, Imperatore N, Crudele A, Ferretti F, Nobili V, Miele L, Gerbino N, Caporaso N, Morisco F.

Nutrients. 2018 Sep 5;10(9). pii: E1239. doi: 10.3390/nu10091239.

28.

Breast Cancer Stem Cells.

Crabtree JS, Miele L.

Biomedicines. 2018 Jul 17;6(3). pii: E77. doi: 10.3390/biomedicines6030077. Review.

29.

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score.

Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, Spicer A, Badrock J, Bernuzzi F, Cardinale V, Ainsworth HF, Heneghan MA, Thorburn D, Bathgate A, Jones R, Neuberger JM, Battezzati PM, Zuin M, Taylor-Robinson S, Donato MF, Kirby J, Mitchell-Thain R, Floreani A, Sampaziotis F, Muratori L, Alvaro D, Marzioni M, Miele L, Marra F, Giannini E, Gaudio E, Ronca V, Bonato G, Cristoferi L, Malinverno F, Gerussi A, Stocken DD, Cordell HJ, Hirschfield GM, Alexander GJ, Sandford RN, Jones DE, Invernizzi P, Mells GF; Italian PBC Study Group and the UK–PBC Consortium.

Lancet Gastroenterol Hepatol. 2018 Sep;3(9):626-634. doi: 10.1016/S2468-1253(18)30163-8. Epub 2018 Jul 13.

30.

Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.

Hossain F, Majumder S, Ucar DA, Rodriguez PC, Golde TE, Minter LM, Osborne BA, Miele L.

Front Immunol. 2018 Jun 4;9:1288. doi: 10.3389/fimmu.2018.01288. eCollection 2018. Review.

31.

Inhibition of HER2 Increases JAGGED1-dependent Breast Cancer Stem Cells: Role for Membrane JAGGED1.

Shah D, Wyatt D, Baker AT, Simms P, Peiffer DS, Fernandez M, Rakha E, Green A, Filipovic A, Miele L, Osipo C.

Clin Cancer Res. 2018 Sep 15;24(18):4566-4578. doi: 10.1158/1078-0432.CCR-17-1952. Epub 2018 Jun 12.

32.

Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease.

Dongiovanni P, Meroni M, Mancina RM, Baselli G, Rametta R, Pelusi S, Männistö V, Fracanzani AL, Badiali S, Miele L, Grimaudo S, Petta S, Bugianesi E, Soardo G, Fargion S, Pihlajamäki J, Romeo S, Valenti L.

Hepatol Commun. 2018 Apr 25;2(6):666-675. doi: 10.1002/hep4.1192. eCollection 2018 Jun.

33.

Racial Disparities and Preventive Measures to Renal Cell Carcinoma.

Sims JN, Yedjou CG, Abugri D, Payton M, Turner T, Miele L, Tchounwou PB.

Int J Environ Res Public Health. 2018 May 28;15(6). pii: E1089. doi: 10.3390/ijerph15061089.

34.

Notch1 primes CD4 T cells for T helper type I differentiation through its early effects on miR-29.

Chandiran K, Lawlor R, Pannuti A, Perez GG, Srinivasan J, Golde TE, Miele L, Osborne BA, Minter LM.

Mol Immunol. 2018 Jul;99:191-198. doi: 10.1016/j.molimm.2018.05.002. Epub 2018 May 26.

35.

Notch-1-PTEN-ERK1/2 signaling axis promotes HER2+ breast cancer cell proliferation and stem cell survival.

Baker A, Wyatt D, Bocchetta M, Li J, Filipovic A, Green A, Peiffer DS, Fuqua S, Miele L, Albain KS, Osipo C.

Oncogene. 2018 Aug;37(33):4489-4504. doi: 10.1038/s41388-018-0251-y. Epub 2018 May 10.

PMID:
29743588
36.

Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients.

Basile U, Gulli F, Gragnani L, Pocino K, Napodano C, Miele L, Santini SA, Marino M, Zignego AL, Rapaccini GL.

Dig Liver Dis. 2018 Sep;50(9):938-943. doi: 10.1016/j.dld.2018.03.028. Epub 2018 Apr 4.

PMID:
29709461
37.

Fat Deposits as Manifestation of Alcohol Use Disorder: Madelung's Disease.

Calarco R, Rapaccini G, Miele L.

Clin Gastroenterol Hepatol. 2019 Sep;17(10):A26. doi: 10.1016/j.cgh.2018.04.044. Epub 2018 Apr 26. No abstract available.

PMID:
29705259
38.

Retraction notice to "Notch-1 induces Epithelial-mesenchymal transition consistent with cancer stem cell phenotype in pancreatic cancer cells".

Bao B, Wang Z, Ali S, Kong D, Li Y, Ahmad A, Banerjee S, Azmi AS, Miele L, Sarkar FH.

Cancer Lett. 2018 Jun 1;423:153. doi: 10.1016/j.canlet.2018.03.020.

39.

Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.

Pannuti A, Filipovic A, Hicks C, Lefkowitz E, Ptacek T, Stebbing J, Miele L.

PLoS One. 2018 Mar 23;13(3):e0194790. doi: 10.1371/journal.pone.0194790. eCollection 2018.

40.

Copper/MYC/CTR1 interplay: a dangerous relationship in hepatocellular carcinoma.

Porcu C, Antonucci L, Barbaro B, Illi B, Nasi S, Martini M, Licata A, Miele L, Grieco A, Balsano C.

Oncotarget. 2018 Jan 20;9(10):9325-9343. doi: 10.18632/oncotarget.24282. eCollection 2018 Feb 6.

41.

Treatment of early stage chronic hepatitis C virus infection.

Ponziani FR, Miele L, Tortora A, Furnari M, Bodini G, Pompili M, Gasbarrini A, Giannini EG.

Expert Rev Clin Pharmacol. 2018 May;11(5):519-524. doi: 10.1080/17512433.2018.1447923. Epub 2018 Mar 9. Review.

PMID:
29498556
42.

Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study.

Duarte SMB, Stefano JT, Miele L, Ponziani FR, Souza-Basqueira M, Okada LSRR, de Barros Costa FG, Toda K, Mazo DFC, Sabino EC, Carrilho FJ, Gasbarrini A, Oliveira CP.

Nutr Metab Cardiovasc Dis. 2018 Apr;28(4):369-384. doi: 10.1016/j.numecd.2017.10.014. Epub 2017 Oct 26.

PMID:
29482963
43.

ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models.

Guo S, Zhang C, Bratton M, Mottamal M, Liu J, Ma P, Zheng S, Zhong Q, Yang L, Wiese TE, Wu Y, Ellis MJ, Matossian M, Burow ME, Miele L, Houtman R, Wang G.

Oncotarget. 2018 Jan 8;9(6):6924-6937. doi: 10.18632/oncotarget.24023. eCollection 2018 Jan 23.

44.

A novel patient-derived xenograft model for claudin-low triple-negative breast cancer.

Matossian MD, Burks HE, Bowles AC, Elliott S, Hoang VT, Sabol RA, Pashos NC, O'Donnell B, Miller KS, Wahba BM, Bunnell BA, Moroz K, Zea AH, Jones SD, Ochoa AC, Al-Khami AA, Hossain F, Riker AI, Rhodes LV, Martin EC, Miele L, Burow ME, Collins-Burow BM.

Breast Cancer Res Treat. 2018 Jun;169(2):381-390. doi: 10.1007/s10549-018-4685-2. Epub 2018 Feb 1.

45.

Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma.

Ponziani FR, Spinelli I, Rinninella E, Cerrito L, Saviano A, Avolio AW, Basso M, Miele L, Riccardi L, Zocco MA, Annicchiarico BE, Garcovich M, Biolato M, Marrone G, De Gaetano AM, Iezzi R, Giuliante F, Vecchio FM, Agnes S, Addolorato G, Siciliano M, Rapaccini GL, Grieco A, Gasbarrini A, Pompili M.

World J Hepatol. 2017 Dec 28;9(36):1322-1331. doi: 10.4254/wjh.v9.i36.1322.

46.

Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway.

Kumar D, Haldar S, Gorain M, Kumar S, Mulani FA, Yadav AS, Miele L, Thulasiram HV, Kundu GC.

BMC Cancer. 2018 Jan 8;18(1):52. doi: 10.1186/s12885-017-3876-2.

47.

The sphingosine kinase 2 inhibitor ABC294640 displays anti-non-small cell lung cancer activities in vitro and in vivo.

Dai L, Smith CD, Foroozesh M, Miele L, Qin Z.

Int J Cancer. 2018 May 15;142(10):2153-2162. doi: 10.1002/ijc.31234. Epub 2018 Jan 4.

48.

Nonalcoholic fatty liver disease in patients with psoriasis: a consequence of systemic inflammatory burden?

Prussick RB, Miele L.

Br J Dermatol. 2018 Jul;179(1):16-29. doi: 10.1111/bjd.16239. Epub 2018 May 15. Review.

PMID:
29235656
49.

Hypoxic Induction of Vasorin Regulates Notch1 Turnover to Maintain Glioma Stem-like Cells.

Man J, Yu X, Huang H, Zhou W, Xiang C, Huang H, Miele L, Liu Z, Bebek G, Bao S, Yu JS.

Cell Stem Cell. 2018 Jan 4;22(1):104-118.e6. doi: 10.1016/j.stem.2017.10.005. Epub 2017 Nov 30.

50.

Farmers' Market Utilization among Supplemental Nutrition Assistance Program Recipients in New Orleans, Louisiana: Preliminary Findings.

Nuss H, Skizim M, Afaneh H, Miele L, Sothern M.

Ethn Dis. 2017 Nov 9;27(Suppl 1):295-302. doi: 10.18865/ed.27.S1.295. eCollection 2017.

Supplemental Content

Support Center